OpGen Restarts with $23.6 Million

OpGen Inc., a Madison, Wis.-based provider of microbial genome analysis, has raised $23.6 million in third round funding. The deal represents a restart for OpGen, which last spring laid off two-thirds of its employees due to financial troubles. New backers include CHL Medical Partners, Highland Capital Partners and Versant Ventures, while return backer Mason Wells also participated. Other past investors had included Stonehenge Capital Co. and the State of Wisconsin Investment Board. www.opgen.com